AJP - Lung Watch the video to learn how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Lung Cell Mol Physiol 281: L1361-L1368, 2001;
1040-0605/01 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (18)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schermuly, R. T.
Right arrow Articles by Walmrath, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schermuly, R. T.
Right arrow Articles by Walmrath, D.
Vol. 281, Issue 6, L1361-L1368, December 2001

Combination of nonspecific PDE inhibitors with inhaled prostacyclin in experimental pulmonary hypertension

Ralph Theo Schermuly, Axel Roehl, Norbert Weissmann, Hossein Ardeschir Ghofrani, Hanno Leuchte, Friedrich Grimminger, Werner Seeger, and Dieter Walmrath

Department of Internal Medicine, Justus-Liebig-University Giessen, D-35392 Giessen, Germany

Inhalation of aerosolized prostacyclin (PGI2) exerts selective pulmonary vasodilation, but its effect is rapidly lost after termination of nebulization. Amplification of the vasodilatory response to inhaled PGI2 might be achieved by phosphodiesterase (PDE) inhibitors to stabilize its second messenger, cAMP. We established stable pulmonary hypertension in perfused rabbit lungs by continuous infusion of U-46619. Short-term (10-min) aerosolization maneuvers of PGI2 effected a rapid, moderate decrease in pulmonary arterial pressure, with post-PGI2 vasorelaxation being lost within 10-15 min, accompanied by a marginal reduction in shunt flow. Preceding administration of subthreshold doses of the PDE inhibitors theophylline, dipyridamole, and pentoxifylline via the intravascular or inhalational route, which per se did not influence pulmonary hemodynamics, caused more than doubling of the immediate pulmonary arterial pressure drop in response to PGI2 and marked prolongation of the post-PGI2 vasorelaxation to >60 min (all PDE inhibitors via both routes of application). This was accompanied by a reduction in shunt flow in the case of aerosolized theophylline (27.5%), pentoxifylline (30.5%), and dipyridamole (33.4%). Coaerosolization of PGI2 and PDE inhibitors may be considered as a therapeutic strategy in pulmonary hypertension.

gas exchange; multiple inert gas elimination technique; dipyridamole; pentoxifylline; theophylline; shunt flow; U-46619; ventilation-perfusion ratio; ventilation-perfusion mismatch


This article has been cited by other articles:


Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
H. H. Leuchte, T. Meis, M. El-Nounou, J. Michalek, and J. Behr
Inhalation of endothelin receptor blockers in pulmonary hypertension
Am J Physiol Lung Cell Mol Physiol, April 1, 2008; 294(4): L772 - L777.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
E. Dony, Y-J. Lai, R. Dumitrascu, S. S. Pullamsetti, R. Savai, H. A. Ghofrani, N. Weissmann, C. Schudt, D. Flockerzi, W. Seeger, et al.
Partial reversal of experimental pulmonary hypertension by phosphodiesterase-3/4 inhibition
Eur. Respir. J., March 1, 2008; 31(3): 599 - 610.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
A. Guggilam, M. Haque, E. K. Kerut, E. McIlwain, P. Lucchesi, I. Seghal, and J. Francis
TNF-{alpha} blockade decreases oxidative stress in the paraventricular nucleus and attenuates sympathoexcitation in heart failure rats
Am J Physiol Heart Circ Physiol, July 1, 2007; 293(1): H599 - H609.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
F. Murray, H. H. Patel, R. Y. S. Suda, S. Zhang, P. A. Thistlethwaite, J. X.-J. Yuan, and P. A. Insel
Expression and activity of cAMP phosphodiesterase isoforms in pulmonary artery smooth muscle cells from patients with pulmonary hypertension: role for PDE1
Am J Physiol Lung Cell Mol Physiol, January 1, 2007; 292(1): L294 - L303.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
P. G. Phillips, L. Long, M. R. Wilkins, and N. W. Morrell
cAMP phosphodiesterase inhibitors potentiate effects of prostacyclin analogs in hypoxic pulmonary vascular remodeling
Am J Physiol Lung Cell Mol Physiol, January 1, 2005; 288(1): L103 - L115.
[Abstract] [Full Text] [PDF]

Home page
 Anesth. Analg.Home page
R. Coimbra, A. Razuk-Filho, M. M. Yada-Langui, and M. Rocha-e-Silva
Intraarterial Pulmonary Pentoxifylline Improves Cardiac Performance and Oxygen Utilization After Hemorrhagic Shock: A Novel Resuscitation Strategy
Anesth. Analg., May 1, 2004; 98(5): 1439 - 1446.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
R. T. Schermuly, K. P. Kreisselmeier, H. A. Ghofrani, A. Samidurai, S. Pullamsetti, N. Weissmann, C. Schudt, L. Ermert, W. Seeger, and F. Grimminger
Antiremodeling Effects of Iloprost and the Dual-Selective Phosphodiesterase 3/4 Inhibitor Tolafentrine in Chronic Experimental Pulmonary Hypertension
Circ. Res., April 30, 2004; 94(8): 1101 - 1108.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
H. H. Leuchte, M. Schwaiblmair, R. A. Baumgartner, C. F. Neurohr, T. Kolbe, and J. Behr
Hemodynamic Response to Sildenafil, Nitric Oxide, and Iloprost in Primary Pulmonary Hypertension
Chest, February 1, 2004; 125(2): 580 - 586.
[Abstract] [Full Text] [PDF]

Home page
 Eur. J. Cardiothorac. Surg.Home page
Y. Saiki, Y. Nitta, Y. Tsuru, and K. Tabayashi
Successful weaning from inhaled nitric oxide using dipyridamole
Eur. J. Cardiothorac. Surg., November 1, 2003; 24(5): 837 - 839.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online